ClinVar Miner

Submissions for variant NC_000007.13:g.(?_128475370)_(128478867_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001379017 SCV001576732 likely pathogenic Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant 2020-08-14 criteria provided, single submitter clinical testing This variant is an in-frame deletion of the genomic region encompassing exon(s) 2-8 of the FLNC gene. It preserves the integrity of the reading frame. This variant has not been reported in the literature in individuals with FLNC-related conditions. This variant disrupts the p.Ala193 amino acid residue in FLNC. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21620354, 30734317, 2781633). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.